GleamWall
中文EN

VVOS Vivos Therapeutics, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1716166 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY18.6%
TTM net income YoY-28.6%
TTM EPS YoY23.7%
Revenue 3-yr CAGR12.3%
Net income 3-yr CAGR—

Margins

Gross margin60.0%
Operating margin-105.8%
Net margin-107.2%
FCF margin-88.5%
EBITDA margin-96.2%

Returns

ROE-899.5%
ROA-90.7%
ROIC (approx.)-283.8%
Asset turnover0.85x

Leverage & solvency

Liabilities / assets90.5%
Debt / equity0.77x
Current ratio0.22x
Interest coverage-6.03x

Cash quality & payout

Operating cash flow / net income0.73x
Accruals ratio-24.1%
Payout ratio—
Capex / revenue9.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$17.44M$15.03M
Cost of revenue$6.90M$6.01M
Gross profit$10.54M$9.02M
R&D expense$100,000$100,000
SG&A expense$27.73M$17.88M
Operating income-$19.89M-$11.17M
Interest expense$1.40M—
Pretax income-$21.23M-$11.14M
Net income-$21.17M-$11.14M
EBITDA-$18.59M-$10.59M
EPS (basic)-2.07-2.22
EPS (diluted)-2.07-2.22
Weighted avg. shares (diluted)10.27M5.02M
Balance sheet
Cash & equivalents$2.03M$6.26M
Receivables$1.58M$430,000
Current assets$4.38M$7.47M
PP&E, net$3.76M$3.31M
Goodwill$8.57M$2.84M
Intangibles$4.04M$409,000
Total assets$25.15M$15.28M
Current liabilities$18.08M$4.98M
Short-term debt$8.35M—
Long-term debt$469,000$1.20M
Total debt$8.82M$1.20M
Total liabilities$26.70M$7.33M
Shareholders' equity-$1.49M$7.95M
Net debt$6.79M-$5.06M
Shares outstanding9.29M5.89M
Cash flow statement
Operating cash flow-$15.26M-$12.69M
Capital expenditure$2.34M$568,000
Free cash flow-$17.60M-$13.26M
Investing cash flow-$7.53M-$568,000
Financing cash flow$18.56M$17.88M
Depreciation & amortization$1.31M$581,000
Stock-based compensation$661,000$762,000

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.